ARCHIVES

The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six.

This article is from The Cancer Letter archive.

Vol. 26 No. 25 | June 23, 2000

Download PDF Visit The Full Archive

Related Articles

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

October 8, 1976

Opposition To Lederberg May Have Caused Delay In Panel Appointments; FY 19809 Funds Held Up

October 5, 1979

Access to mammography needs improvement, IOM National Cancer Policy Board report finds.

June 11, 2004

AACI Summarizes Position On New Core Guidelines

May 16, 1980

Postdoc Fabricated Results In Published Study, ORI Says.

October 27, 2000

Trials Approved In October

December 28, 2001